Author:
Zhang Pan,Lai Ze-Lin,Chen Hui-Fen,Zhang Min,Wang An,Jia Tao,Sun Wen-Qin,Zhu Xi-Min,Chen Xiao-Feng,Zhao Zheng,Zhang Jun
Funder
National Natural Science Foundation of China
opening grant from Key Laboratory of Brain Functional Genomics (ECNU), Ministry of Education
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
2. Beretta GD, Milesi L, Pessi MA, Mosconi S, Labianca R. Adjuvant treatment of colorectal cancer. Surg Oncol. 2004;13:63–73.
3. Hector S, Prehn JH. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochim Biophys Acta. 2009;1795:117–29.
4. Kolinsky K, Shen BQ, Zhang YE, Kohles J, Dugan U, Zioncheck TF, et al. In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models. Mol Cancer Ther. 2009;8:75–82.
5. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan study group. N Engl J Med. 2000;343:905–14.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献